IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 143 filers reported holding IMMUNOGEN INC in Q2 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $654,000 | -23.1% | 320,809 | +1.0% | 0.00% | 0.0% |
| Q3 2016 | $851,000 | -13.2% | 317,487 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $980,000 | -62.2% | 318,234 | +4.6% | 0.00% | -66.7% |
| Q1 2016 | $2,591,000 | -33.6% | 304,129 | +5.8% | 0.00% | -40.0% |
| Q4 2015 | $3,901,000 | +42.2% | 287,491 | +0.6% | 0.01% | +25.0% |
| Q3 2015 | $2,744,000 | -34.7% | 285,854 | -2.1% | 0.00% | -20.0% |
| Q2 2015 | $4,199,000 | +98.7% | 292,035 | +23.7% | 0.01% | +66.7% |
| Q1 2015 | $2,113,000 | +47.9% | 236,137 | +0.8% | 0.00% | +50.0% |
| Q4 2014 | $1,429,000 | -42.9% | 234,286 | -0.8% | 0.00% | -33.3% |
| Q3 2014 | $2,502,000 | -10.1% | 236,217 | +0.6% | 0.00% | -25.0% |
| Q2 2014 | $2,782,000 | -24.4% | 234,797 | -4.7% | 0.00% | -20.0% |
| Q1 2014 | $3,680,000 | +2.3% | 246,462 | +0.5% | 0.01% | 0.0% |
| Q4 2013 | $3,597,000 | -15.8% | 245,199 | -2.3% | 0.01% | -28.6% |
| Q3 2013 | $4,271,000 | +7.1% | 250,923 | +4.4% | 0.01% | 0.0% |
| Q2 2013 | $3,988,000 | – | 240,378 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |